DAXXIFY
NDC 72960-112 · Revance Therapeutics, Inc.
Packages
72960-112-01 — 1 VIAL, SINGLE-USE in 1 CARTON (72960-112-01) / 1.2 mL in 1 VIAL, SINGLE-USE
72960-112-02 — 1 VIAL, SINGLE-USE in 1 CARTON (72960-112-02) / 1.2 mL in 1 VIAL, SINGLE-USE
Billed under HCPCS
J0589 — Injection, daxibotulinumtoxina-lanm, 1 unit Medicare Part B payment limit (ASP + 6%): $3.25
Related Codes
Same active ingredient
FDA lists these products with the same active ingredient.
0023-1145 — onabotulinumtoxinA, 0023-3919 — onabotulinumtoxinA, 0023-3921 — onabotulinumtoxinA, 0023-9232 — onabotulinumtoxinA, 0259-1605 — incobotulinumtoxinA, 0259-1610 — incobotulinumtoxinA, 0259-1620 — incobotulinumtoxinA, 0259-4110 — incobotulinumtoxinA, 0259-4150 — incobotulinumtoxinA, 0299-5962 — Botulinum Toxin Type A, 15054-0500 — Botulinum Toxin Type A, 15054-0530 — Botulinum Toxin Type A, 46783-160 — incobotulinumtoxinA, 46783-161 — incobotulinumtoxinA, 46783-165 — incobotulinumtoxinA, 72301-595 — Prabotulinum Toxin Type A, 85766-155 — onabotulinumtoxinA
Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q4 (October 2026 release). All data sources · How to read the labels
Current data releases:ICD-10-CM FY2027 · ICD-10-PCS FY2027 · HCPCS October 2026 · MS-DRG v44 · Medicare Code Editor v44.0 · NCCI PTP Q4 2026 · MUE Q4 2026 · NCD code lists 2026-01 · LCD export September 28, 2026 · All releases and sources